N-((1H-Indol-3-yl)methyl)-1-(2-methoxyphenyl)methanamine

Catalog No. :
ACHESL539
CAS No. :
625409-25-8
Molecular Formula :
C17H18N2O
Molecular Weight :
266.34

IUPAC Name:N-((1H-indol-3-yl)methyl)-1-(2-methoxyphenyl)methanamine

N-((1H-Indol-3-yl)methyl)-1-(2-methoxyphenyl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$97.00Login to see priceInquiryInquiry
1g95%$204.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((1H-Indol-3-yl)methyl)-1-(2-methoxyphenyl)methanamine
IUPAC NameN-((1H-indol-3-yl)methyl)-1-(2-methoxyphenyl)methanamine
MDL No.MFCD01135668
Molecular FormulaC17H18N2O
Molecular Weight266.34
SMILESCOC1=CC=CC=C1CNCC2=CNC3=C2C=CC=C3
InChI KeyVMSZEVXBSPOKIL-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB007253;AKOS B023248;(1 H-INDOL-3-YLMETHYL)-(2-METHOXY-BENZYL)-AMINE;ART-CHEM-BB B023248;CHEMBRDG-BB 5538918;(1H-indol-3-ylmethyl)(2-methoxybenzyl)amine(SALTDATA: FREE);N-((1H-Indol-3-yl)methyl)-1-(2-methoxyphenyl)methanamine;1H-Indole-3-methanamine, N-[(2-methoxyphenyl)methyl]-
CAS No.625409-25-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHESL539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOHWJ835 route compound structure diagram
    ACOHWJ835487-89-8 In Stock
  4. Then
  5. ACHESL539 route product structure diagram
    ACHESL539625409-25-8
Inquiry

2. ACHESL539 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHESL539 route product structure diagram
    ACHESL539625409-25-8
Inquiry

Comments (0)